Literature DB >> 21937644

A sequence within the varicella-zoster virus (VZV) OriS is a negative regulator of DNA replication and is bound by a protein complex containing the VZV ORF29 protein.

Mohamed I Khalil1, Ann Arvin, Jeremy Jones, William T Ruyechan.   

Abstract

The architecture of the varicella-zoster virus (VZV) origin of DNA replication (OriS) differs significantly from that of the herpes simplex virus (HSV) DNA replication origin. Novel aspects of the VZV OriS include a GA-rich region, three binding sites for the VZV origin-binding protein (OBP) all on the same strand and oriented in the same direction, and a partial OBP binding site of unknown function. We have designated this partial binding site Box D and have investigated the role it plays in DNA replication and flanking gene expression. This has been done with a model system using a replication-competent plasmid containing OriS and a replication- and transcription-competent dual-luciferase reporter plasmid containing both the OriS and the intergenic region between VZV open reading frames (ORFs) 62 and 63. We have found that (i) Box D is a negative regulator of DNA replication independent of flanking gene expression, (ii) the mutation of Box D results in a decrease in flanking gene expression, thus a sequence within the VZV OriS affects transcription, which is in contrast to results reported for HSV-1, (iii) there is a specific Box D complex formed with infected cell extracts in electrophoretic mobility shift assay experiments, (iv) supershift assays show that this complex contains the VZV ORF29 single-strand DNA-binding protein, and (v) the formation of this complex is dependent on the presence of CGC motifs in Box D and its downstream flanking region. These findings show that the VZV ORF29 protein, while required for DNA replication, also plays a novel role in the suppression of that process.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937644      PMCID: PMC3209344          DOI: 10.1128/JVI.05501-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.

Authors:  Yasuyuki Gomi; Hiroki Sunamachi; Yasuko Mori; Kazuhiro Nagaike; Michiaki Takahashi; Koichi Yamanishi
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  E2F proteins are posttranslationally modified concomitantly with a reduction in nuclear binding activity in cells infected with herpes simplex virus 1.

Authors:  S J Advani; R R Weichselbaum; B Roizman
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Herpes simplex virus type 1 origins of DNA replication play no role in the regulation of flanking promoters.

Authors:  Bretton C Summers; David A Leib
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

4.  Pocket protein p130/Rb2 is required for efficient herpes simplex virus type 1 gene expression and viral replication.

Authors:  G L Ehmann; H A Burnett; S L Bachenheimer
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Physical interaction between two varicella zoster virus gene regulatory proteins, IE4 and IE62.

Authors:  M L Spengler; W T Ruyechan; J Hay
Journal:  Virology       Date:  2000-07-05       Impact factor: 3.616

6.  A 67-base-pair segment from the Ori-S region of herpes simplex virus type 1 encodes origin function.

Authors:  S Deb; M Doelberg
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

7.  Physical and functional interaction between the varicella zoster virus IE63 and IE62 proteins.

Authors:  Jennifer M Lynch; Terri K Kenyon; Charles Grose; John Hay; William T Ruyechan
Journal:  Virology       Date:  2002-10-10       Impact factor: 3.616

8.  Cis and trans elements regulating expression of the varicella zoster virus gI gene.

Authors:  H He; D Boucaud; J Hay; W T Ruyechan
Journal:  Arch Virol Suppl       Date:  2001

9.  Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo.

Authors:  Hideki Ito; Marvin H Sommer; Leigh Zerboni; Hongying He; Dwayne Boucaud; John Hay; William Ruyechan; Ann M Arvin
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  Mutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo.

Authors:  Bunji Sato; Hideki Ito; Stewart Hinchliffe; Marvin H Sommer; Leigh Zerboni; Ann M Arvin
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

View more
  7 in total

1.  New insights into replication origin characteristics in metazoans.

Authors:  Christelle Cayrou; Philippe Coulombe; Aurore Puy; Stephanie Rialle; Noam Kaplan; Eran Segal; Marcel Méchali
Journal:  Cell Cycle       Date:  2012-02-15       Impact factor: 4.534

2.  Cellular transcription factor YY1 mediates the varicella-zoster virus (VZV) IE62 transcriptional activation.

Authors:  Mohamed I Khalil; Marvin Sommer; Ann Arvin; John Hay; William T Ruyechan
Journal:  Virology       Date:  2013-12-12       Impact factor: 3.616

3.  An Sp1/Sp3 site in the downstream region of varicella-zoster virus (VZV) oriS influences origin-dependent DNA replication and flanking gene transcription and is important for VZV replication in vitro and in human skin.

Authors:  Mohamed I Khalil; Makeda Robinson; Marvin Sommer; Ann Arvin; John Hay; William T Ruyechan
Journal:  J Virol       Date:  2012-08-29       Impact factor: 5.103

4.  Varicella-zoster virus (VZV) origin of DNA replication oriS influences origin-dependent DNA replication and flanking gene transcription.

Authors:  Mohamed I Khalil; Marvin H Sommer; John Hay; William T Ruyechan; Ann M Arvin
Journal:  Virology       Date:  2015-03-17       Impact factor: 3.616

5.  Differential effects of Sp cellular transcription factors on viral promoter activation by varicella-zoster virus (VZV) IE62 protein.

Authors:  Mohamed I Khalil; William T Ruyechan; John Hay; Ann Arvin
Journal:  Virology       Date:  2015-07-23       Impact factor: 3.616

Review 6.  Herpes simplex viruses: mechanisms of DNA replication.

Authors:  Sandra K Weller; Donald M Coen
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-09-01       Impact factor: 10.005

7.  Effects of Shield1 on the viral replication of varicella‑zoster virus containing FKBP‑tagged ORF4 and 48.

Authors:  Shuying Li; Zhanjun Liu; Ji Li; Aihua Liu; Lihua Zhu; Kui Yu; Ke Zhang
Journal:  Mol Med Rep       Date:  2017-11-06       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.